F10 and cancer: One study was a pooled analysis of the subgroup of patients with cancer in “sister” trials.17 Four trials13,18–20 compared factor Xa inhibitors with LMWH, and three12,14,17 compared factor Xa inhibitors with VKA as a VTE treatment.